Skip to content

Comparison between the effects of PCIA tramadol, hydromorphone and PCEA ropivacaine on one-year outcome after cesarean section

Comparison between the effects of PCIA tramadol, hydromorphone and PCEA ropivacaine on one-year outcome after cesarean section

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019381
Enrollment
Unknown
Registered
2018-11-08
Start date
2018-11-09
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caesarean section

Interventions

Group 1:PCIA with tramadol
Group 2:PCIA with hydromorphone
Group 3:PCEA with ropivacaine

Sponsors

Second Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20 to 40 years old; 2. ASA score I, II; 3. uncomplicated and singleton full-term pregnancy; 4. voluntarily to receive cesarean section and postoperative controlled analgesia; 5. consent to participate the study.

Exclusion criteria

Exclusion criteria: 1. with history of mental disorders or psychotropic substances use; 2. with history of neurological diseases such as epilepsy 3. with history of previously known diagnosed depression; 4. with suicidal ideation or history of suicide; 5. with history of drugalcohol or opioid abuse; 6. with monoamine oxidase (MAO) inhibitor treatment at present or in the past 14 days; 7. participating in other clinical studies 8. with severe heart disease, brain disease, liver disease and kidney disease; 9. be allergic to tramadol or opioids; 10. with any contraindication for combined spinal epidural anesthesia; 11. incapable of communication or cooperation.

Design outcomes

Primary

MeasureTime frame
Chronic pain questionnaire;

Secondary

MeasureTime frame
SF-8TM;EPDS and depression morbidity;GAD-7;Complications;Readmission;Morbidity of infant;

Countries

China

Contacts

Public ContactHong Li

The Second Affiliated Hospital of Army Medical University

472217836@qq.com+86 13608380123

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026